Clinical Trials on Secondary Sjogren

Total 1703 results

Tianjin Medical University Cancer Institute and...

Recruiting

Microwave Ablation With Splenic Artery Occlusion for Secondary Hypersplenism

Secondary Hypersplenism

China
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Completed

Study of Lung Function in Children Who Have Undergone Bone Marrow Transplantation

Long-term Effects Secondary to Cancer Therapy in Children | Pulmonary Complications

United States
Herlev Hospital

Recruiting

Conservative Treatment or Resuturing Among Women With Perineal Wound Dehiscence After Vaginal Labour (HEAL)

Episiotomy; Dehiscence | Dehiscence Wound | Secondary Perineal Tear

Denmark
National Center for Research Resources (NCRR)

Completed

Acute Regulation of Parathyroid Hormone by Dietary Phosphate

Secondary Hyperparathyroidism

United States
Montefiore Medical Center

Terminated

Cinacalcet to Treat Hypercalcemia in Renal Transplant Recipients

Secondary Hyperparathyroidism | Hypercalcemia

United States
Haukeland University Hospital
University of Bergen

Completed

Tissue Characterisation by Endoscopic GI-elastography

Secondary Malignant Neoplasm of Lymph Node | Disorder of Upper Gastrointestinal Tract | Pancreatic Nodule | Secondary and Unspecified Malignant Neoplasm of Retroperitoneal Lymph Nodes

Norway
Antisoma Research

Unknown

Phase III Randomized Study of Amonafide (AS1413) and Cytarabine Versus Daunorubicin and Cytarabine in Patients With Secondary Acute Myeloid Leukemia (AML)- the ACCEDE Study

Secondary Acute Myeloid Leukemia (Secondary AML, sAML)

Korea, Republic of, United States, Spain, United Kingdom, Australia, Austria, Taiwan, Israel, Italy, Belgium, Germany, France, Romania, Estonia, Canada, Ukraine, Ecuador, Hungary, Poland, Chile, Argentina, Czech Republic, Russian Federation
Kerstyn C. Zalesin, M.D.
Abbott

Completed

Trial Of Paricalcitol and Cholecalciferol(Vitamin D3) in the Treatment Of Secondary Hyperparathyroidism in Patients After ROUX-EN-Y Gastric Bypass Surgery (ExtenD)

Gastric Bypass | Parathyroid Hormone

United States
Dent Neuroscience Research Center

Withdrawn

Effect of Primidone on Platelet Responsiveness in Patients Determined to be Clopidogrel Resistant

Clopidogrel Resistance | Secondary Stroke Prevention

United States
Octapharma

Completed

The Effect of Subcutaneous Immunoglobulin Gammanorm on the Distribution of IgG Subclasses and on Immunity of Patients With Secondary Immunodeficiency

Secondary Immune Deficiency

France
Ministry of Health, Saudi Arabia

Not yet recruiting

The Study of Quadruple Therapy Intranasal Insulin, Zinc, Gabapentin, Ice Cube Stimulation for Post COVID-19 Smell and Taste Dysfunctions (COVID-19)

Taste Disorders | Smell Disorder | Smell Dysfunction | Taste Disorder, Secondary, Sweet | Taste Disorder, Secondary, Bitter
University of Sao Paulo General Hospital

Active, not recruiting

N-acetylcysteine for Primary Sjögren's Syndrome (NACSS)

Sicca Syndrome | Sjögren Syndrome

Brazil
Galapagos NV

Terminated

A Study Evaluating the Effects of GLPG3970 Given as an Oral Treatment for 12 Weeks in Adults With Active Primary Sjögren's Syndrome (pSS) (GLIDER)

Primary Sjögren Syndrome

Germany, Greece, Poland, Hungary, Ukraine
Göteborg University

Completed

A Study of Flt3-Ligand Levels in Sjögrens Syndrome

Sjogrens Syndrome

Sweden
Amgen

Completed

Compare the Efficacy of Cinacalcet vs Traditional Vitamin D for Secondary Hyperparathyroidism (SHPT) Among Subjects Undergoing Hemodialysis

Hyperparathyroidism, Secondary
KAI Pharmaceuticals

Completed

Safety, Tolerability and Pharmacokinetics of Etelcalcetide in Hemodialysis Patients With Secondary Hyperparathyroidism

Hyperparathyroidism, Secondary

United States, Australia
Repros Therapeutics Inc.

Completed

The Effect on Androxal Versus Androgel on Morning Testosterone in Men With Secondary Hypogonadism (Low Testosterone)

Secondary Hypogonadism

United States
Repros Therapeutics Inc.

Completed

Study to Evaluate the Safety and Efficacy of Androxal™ Treatment in Men With Secondary Hypogonadism

Secondary Hypogonadism

United States
Repros Therapeutics Inc.

Completed

Phase III Study to Evaluated Morning Testosterone Normalization in Men With Secondary Hypogonadism

Secondary Hypogonadism

United States
Repros Therapeutics Inc.

Completed

Normalization of Morning Testosterone Levels in Men With Secondary Hypogonadism

Secondary Hypogonadism

United States
Repros Therapeutics Inc.

Completed

Safety Study of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism

Secondary Hypogonadism

United States
Repros Therapeutics Inc.

Completed

An Extension Study of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism

Secondary Hypogonadism
Université Catholique de Louvain

Completed

Reliability of Measuring the Area and Intensity of Secondary Hyperalgesia Induced by High Frequency Stimulation

Hyperalgesia, Secondary

Belgium
The Second Hospital of Anhui Medical University

Unknown

Comparison of Total Parathyroidectomy With and Without Autotransplantation

Secondary Hyperparathyroidism

China
OPKO Health, Inc.

Completed

Repeated-dose Safety, Efficacy, Pharmacokinetic and Pharmacodynamic of CTAP101, Immediate-release Calcifediol, High-dose Cholecalciferol, and Paricalcitol Plus Low-dose Cholecalciferol in Patients With Secondary Hyperparathyroidism, Chronic Kidney Disease 3-4 and Vitamin D Insufficiency

Vitamin D Insufficiency | CKD Stage 4 | CKD Stage 3 | Secondary Hyperparathyroidism Due to Renal Causes

United States
Abramson Cancer Center of the University of Pennsylvania
National Cancer Institute (NCI)

Completed

Partial Breast Radiation Therapy in Treating Women Undergoing Breast Conservation Therapy for Early-Stage Breast Cancer

Breast Cancer | Long-term Effects Secondary to Cancer Therapy in Adults | Skin Reactions Secondary to Radiation Therapy

United States
Radboud University Medical Center

Completed

Effectiveness of Adhesive Containing MDPB

Secondary Caries
University Hospital, Linkoeping

Completed

Infusion Rate and Volume Kinetics for Hyperoncotic Albumine in Healthy Subjects ((RAV))

Edema Secondary

Sweden
Federal University of São Paulo

Completed

Laser Therapy to Treat the Dry Mouth of Sjogren's Syndrome

XEROSTOMIA | KERATOCONJUNCTIVITIS SICCA | SICCA SYNDROME | PRIMARY SJOGREN SYNDROME

Brazil
Novartis Pharmaceuticals

Terminated

A Phase 2 Study to Evaluate the Safety and Efficacy of LOU064 in Patients With Moderate to Severe Sjögren's Syndrome (LOUiSSe)

Sjögren Syndrome

Spain, United States, Belgium, Hungary, Germany, Switzerland, Australia, Denmark, China, Taiwan, United Kingdom, Bulgaria
Ankara Education and Research Hospital

Completed

Effects of Primary Sjögren's Syndrome on Female Genitalia and Sexual Functions

Primary Sjögren Syndrome

Turkey
University Hospital, Brest

Unknown

Eye Dryness Evaluation in Primary Sjögren's Syndrome (PEPSS)

Primary Sjögren Syndrome
Federal University of São Paulo

Completed

Resistance Exercise in Woman With Primary Sjörgen Syndrome.

Primary Sjögren Syndrome
Charite University, Berlin, Germany

Completed

Low Dose Cyclosporin A in Primary Sjögren Syndrome (CYPRESS)

Sjögren´s Syndrome

Germany
Centre Georges Francois Leclerc

Recruiting

Value of Information of Secondary dAta in ONCOGEnetics (VISAGE-ONCO)

Cancer | Genetic Predisposition | Secondary Fundings

France
Herantis Pharma Plc.

Active, not recruiting

Clinical Study With Lymfactin® in the Treatment of Patients With Secondary Lymphedema (AdeLE) (AdeLE)

Secondary Lymphedema

Finland, Sweden
Herantis Pharma Plc.

Terminated

A Phase I Study With Lymfactin® in the Treatment of Patients With Secondary Lymphedema

Secondary Lymphedema

Finland
State University of New York at Buffalo

Completed

The Effect of Botulinum Toxin A on Headache Attributed to TMD

Secondary Headache Disorder

United States
Poznan University of Medical Sciences

Completed

ICF in Secondary Prevention of Cardiovascular Disease

Cardiovascular Diseases | Risk Factor, Cardiovascular | Secondary Prevention

Poland
Repros Therapeutics Inc.

Completed

To Evaluate Sperm Parameters in Men With Secondary Hypogonadism Previously Treated With Topical Testosterone

Secondary Hypogonadism

United States
Repros Therapeutics Inc.

Completed

Study to Evaluate the Safety and Efficacy of Androxal Treatment in Men With Secondary Hypogonadism (ZA-003Ext)

Secondary Hypogonadism

United States
Mansoura University

Completed

A 2-year Clinical Performance of Two Different Ion-releasing Bulk-fill Restorative Materials Posterior Cavities

Secondary Caries

Egypt
Institute of Hematology & Blood Diseases Hospital

Not yet recruiting

Secondary Prophylaxis of CMV Infection Using Letermovir After HID-HSCT

To Evaluate the Efficacy and Safety of Secondary Prophylaxis of CMV Reactivation
University Ghent

Completed

Dose Titration of Lisinopril in Children Aged 1 to 18 Years With Primary or Secondary Hypertension (Lisi-ped)

Primary Hypertension | Secondary Hypertension

Belgium
OPKO Health, Inc.

Withdrawn

Four Week, Pharmacodynamic/Pharmacokinetic, Efficacy, and Safety Study of Lunacalcipol (CTA018) (2007)

Secondary Hyperparathyroidism (SHPT) | Stage 5 Chronic Kidney Disease (CKD) | Hemodialysis (HD)
Hospital Nacional Profesor Alejandro Posadas

Completed

Amniotic Membrane Treatment for Hyposecretory Dry Eye

Dry Eye Syndromes | Sjogren Syndrome With Keratoconjunctivitis

Argentina
Repros Therapeutics Inc.

Completed

Phase III Study to Evaluate Morning Testosterone Normalization in Overweight Men With Secondary Hypogonadism

Secondary Hypogonadism

United States
Boehringer Ingelheim

Completed

Safety of Dabigatran Etexilate in Blood Clot Prevention in Children

Venous Thromboembolism | Secondary Prevention

United States, Norway, Canada, Belgium, Thailand, Italy, Germany, Turkey, Austria, Hungary, Czechia, Taiwan, Israel, Brazil, Denmark, France, Lithuania, Mexico, Russian Federation, Sweden, Switzerland, Ukraine
Rigshospitalet, Denmark

Completed

Delineating Areas of Secondary Hyperalgesia: Influence of the Assessment Method

Measurements of Areas of Secondary Hyperalgesia
BioMS Technology Corp.

Terminated

Efficacy and Safety of MBP8298 in Subjects With Secondary Progressive Multiple Sclerosis (MAESTRO-03)

Multiple Sclerosis, Secondary Progressive

Clinical Trials on Secondary Sjogren

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kyrgyzstan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations